Novartis AG
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
Last updated:
Abstract:
The present invention relates to therapeutic uses of compounds of formula (I) or a pharmaceutically acceptable salt thereof ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
28 Feb 2019
Issue date:
17 Dec 2019